Brief: Senti Biosciences - On Aug 7 Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Of Listing From Nasdaq
11/08/2023 13:35
Aug 11 (Reuters) - Senti Biosciences Inc SNTI.O :
* SENTI BIOSCIENCES - ON AUG 7, CO GOT NOTICE OF DELISTING
OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD;
TRANSFER OF LISTING FROM NASDAQ
Source: [https://bit.ly/3DNS3aF]
Further company coverage: SNTI.O
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates